Featured
Oncology
Capecitabine Tablets 500mg
Tablet — 500mg
WHO-GMP
EU-GMP
US-FDA
Product Overview
Oral fluoropyrimidine carbamate antineoplastic agent. Converted to 5-fluorouracil at the tumor site for targeted action.
Indications
Metastatic breast cancer, colorectal cancer
Dosage Forms & Strength
Available Forms
Tablet
Strength
500mg
Regulatory Approvals
WHO-GMP
EU-GMP
US-FDA